Artykuły udostępnione publicznie: - Thomas WisniewskiWięcej informacji
OgółemNIHDoDNHMRCCIHRMRCEuropean CommissionVANSFCNIHRGovernment of SpainAutism Speaks Inc, USADFGSwedish Research CouncilNSFAHAAlzheimers's UKWellcomeSNSFHHMIFWFFWOFRQSAcademy of FinlandKnut and Alice Wallenberg FoundationA*StarVersus Arthritis, UKBBSRCDMTParkinson's UKANRState of CalifoniaBMBFFRQNTGovernment of ItalyGovernment of Argentina
Niedostępne w żadnym miejscu: 7
Localized proteomics of individual neurons isolated from formalin-fixed, paraffin-embedded tissue sections using laser capture microdissection
E Drummond, S Nayak, B Ueberheide, T Wisniewski
Current proteomic approaches applied to brain function, 289-301, 2017
Upoważnienia: US National Institutes of Health
Use of Affinity Purification–Mass Spectrometry to Identify Phosphorylated Tau Interactors in Alzheimer’s Disease
G Pires, B Ueberheide, T Wisniewski, E Drummond
Alzheimer’s Disease: Methods and Protocols, 263-277, 2022
Upoważnienia: US National Institutes of Health
Gait dysfunction in Alzheimer disease
T Wisniewski, AV Masurkar
Handbook of Clinical Neurology 196, 267-274, 2023
Upoważnienia: US National Institutes of Health
Cholesterol deficiency as a mechanism for autism: A valproic acid model
MR Peltier, J Behbodikhah, HA Renna, S Ahmed, A Srivastava, Y Arita, ...
Journal of Investigative Medicine 72 (1), 80-87, 2024
Upoważnienia: US National Institutes of Health
MRI signature of α-Synuclein Pathology in Asymptomatic stages and a memory Clinic Population
LEM Wisse, N Spotorno, M Rossi, MJ Grothe, A Mammana, P Tideman, ...
JAMA neurology 81 (10), 1051-1059, 2024
Upoważnienia: Knut and Alice Wallenberg Foundation, European Commission
Diagnosis of Prion Diseases
R Rubenstein, RB Petersen, T Wisniewski
Manual of Molecular and Clinical Laboratory Immunology, 682-695, 2016
Upoważnienia: US National Institutes of Health
IC‐P‐112: MRI of Histological Tissue: Effect of Passive Gadolinium‐Staining
DM Hoang, A Boutajangout, A Bertrand, S Pun, L Fakri-Bouchet, ...
Alzheimer's & Dementia 6, S45-S45, 2010
Upoważnienia: US National Institutes of Health
Dostępne w jakimś miejscu: 205
Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature
PT Nelson, I Alafuzoff, EH Bigio, C Bouras, H Braak, NJ Cairns, ...
Journal of Neuropathology & Experimental Neurology 71 (5), 362-381, 2012
Upoważnienia: US National Institutes of Health, German Research Foundation
Clearance systems in the brain—implications for Alzheimer disease
JM Tarasoff-Conway, RO Carare, RS Osorio, L Glodzik, T Butler, ...
Nature reviews neurology 11 (8), 457-470, 2015
Upoważnienia: US National Institutes of Health, Swedish Research Council
Primary age-related tauopathy (PART): a common pathology associated with human aging
JF Crary, JQ Trojanowski, JA Schneider, JF Abisambra, EL Abner, ...
Acta neuropathologica 128, 755-766, 2014
Upoważnienia: US National Institutes of Health, Dunhill Medical Trust, UK, UK Medical …
Alzheimer’s disease: experimental models and reality
E Drummond, T Wisniewski
Acta neuropathologica 133, 155-175, 2017
Upoważnienia: US National Institutes of Health
Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons
JW Um, HB Nygaard, JK Heiss, MA Kostylev, M Stagi, A Vortmeyer, ...
Nature neuroscience 15 (9), 1227-1235, 2012
Upoważnienia: US National Institutes of Health
The neuropathology of autism: defects of neurogenesis and neuronal migration, and dysplastic changes
J Wegiel, I Kuchna, K Nowicki, H Imaki, J Wegiel, E Marchi, SY Ma, ...
Acta neuropathologica 119, 755-770, 2010
Upoważnienia: US National Institutes of Health, Autism Speaks Inc, USA
Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer aβ oligomer bound to cellular prion protein
JW Um, AC Kaufman, M Kostylev, JK Heiss, M Stagi, H Takahashi, ...
Neuron 79 (5), 887-902, 2013
Upoważnienia: US National Institutes of Health
FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer’s disease
L Mosconi, R Mistur, R Switalski, WH Tsui, L Glodzik, Y Li, E Pirraglia, ...
European journal of nuclear medicine and molecular imaging 36, 811-822, 2009
Upoważnienia: US National Institutes of Health
Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy
GG Kovacs, I Ferrer, LT Grinberg, I Alafuzoff, J Attems, H Budka, ...
Acta neuropathologica 131, 87-102, 2016
Upoważnienia: US National Institutes of Health, US Department of Veterans Affairs …
Systematic review of potential health risks posed by pharmaceutical, occupational and consumer exposures to metallic and nanoscale aluminum, aluminum oxides, aluminum hydroxide …
CC Willhite, NA Karyakina, RA Yokel, N Yenugadhati, TM Wisniewski, ...
Critical reviews in toxicology 44 (sup4), 1-80, 2014
Upoważnienia: US National Institutes of Health
Amyloid β protein dimer-containing human CSF disrupts synaptic plasticity: prevention by systemic passive immunization
I Klyubin, V Betts, AT Welzel, K Blennow, H Zetterberg, A Wallin, ...
Journal of Neuroscience 28 (16), 4231-4237, 2008
Upoważnienia: US National Institutes of Health
Traumatic brain injury and Alzheimer's disease: the cerebrovascular link
J Ramos-Cejudo, T Wisniewski, C Marmar, H Zetterberg, K Blennow, ...
EBioMedicine 28, 21-30, 2018
Upoważnienia: US National Institutes of Health, American Heart Association
A novel human disease with abnormal prion protein sensitive to protease
P Gambetti, Z Dong, J Yuan, X Xiao, M Zheng, A Alshekhlee, R Castellani, ...
Annals of Neurology: Official Journal of the American Neurological …, 2008
Upoważnienia: US National Institutes of Health
Informacje na temat publikacji i finansowania automatycznie określa program komputerowy